This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Advances in the Understanding and Treatment of Melanoma
Organizer(s): Patrick Hwu, Elizabeth Grimm and James Mulé
Date: January 18 - 23, 2006
Location: Hilton Santa Fe Historic Plaza Hotel, Santa Fe, NM, USA
Supported by The Director's Fund
Summary of Meeting:
Because of its inherent immunogenicity and abundant vascularity, melanoma provides a unique opportunity to develop novel molecular, immunologic and anti-angiogenic therapies that can then be generalized to other diseases. Some consider melanoma the 'E.coli' in which to develop new cancer therapies. Three of the most exciting areas in this field involve molecular targeting of specific pathways, cancer vaccines and immunotherapy, and anti-vascular therapies. However, none of these areas alone are likely to have significant impact in the disease, and the use of multiple approaches will be critical. While there are many meetings which focus on a particular treatment approach, this program will bring together a multidisciplinary group that will explore the interactions among these distinct therapeutic strategies. We envision that basic and clinical research in melanoma will lead the way in integrating molecular targeting, immunologic, and anti-vascular therapies and can serve as a model for the treatment of other diseases.
Scholarship Deadline: September 19 2005
Discounted Abstract Deadline: September 19 2005
Abstract Deadline: October 11 2005
Discounted Registration Deadline: November 18 2005
We gratefully acknowledge additional support for this conference from:
Melanoma Research FoundationNovartis Institutes for BioMedical ResearchSchering-Plough Corporation
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

3M Pharmaceuticals

Chiron Corporation
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1 R13 CA117400-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found